<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zheng Q</submitter><funding>NIDA NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>974-982</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11754111</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>637(8047)</volume><pubmed_abstract>Histone H3 monoaminylations at Gln5 represent an important family of epigenetic marks in brain that have critical roles in permissive gene expression&lt;sup>1-3&lt;/sup>. We previously demonstrated that serotonylation&lt;sup>4-10&lt;/sup> and dopaminylation&lt;sup>9,11-13&lt;/sup> of Gln5 of histone H3 (H3Q5ser and H3Q5dop, respectively) are catalysed by transglutaminase 2 (TG2), and alter both local and global chromatin states. Here we found that TG2 additionally functions as an eraser and exchanger of H3 monoaminylations, including H3Q5 histaminylation (H3Q5his), which displays diurnally rhythmic expression in brain and contributes to circadian gene expression and behaviour. We found that H3Q5his, in contrast to H3Q5ser, inhibits the binding of WDR5, a core member of histone H3 Lys4 (H3K4) methyltransfera</pubmed_abstract><journal>Nature</journal><pubmed_title>Bidirectional histone monoaminylation dynamics regulate neural rhythmicity.</pubmed_title><pmcid>PMC11754111</pmcid><funding_grant_id>R35 GM150676</funding_grant_id><funding_grant_id>R01 GM086868</funding_grant_id><funding_grant_id>R01 MH116900</funding_grant_id><funding_grant_id>P30 CA013330</funding_grant_id><funding_grant_id>S10 OD030286</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>R37 GM086868</funding_grant_id><funding_grant_id>R01 DA056595</funding_grant_id><funding_grant_id>T32 DA007135</funding_grant_id><funding_grant_id>P50 CA192937</funding_grant_id><funding_grant_id>P01 DA047233</funding_grant_id><funding_grant_id>R35 GM138386</funding_grant_id><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Shen L</pubmed_authors><pubmed_authors>Weekley BH</pubmed_authors><pubmed_authors>Stransky S</pubmed_authors><pubmed_authors>Zhang N</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Cunningham AM</pubmed_authors><pubmed_authors>Thompson RE</pubmed_authors><pubmed_authors>Molina H</pubmed_authors><pubmed_authors>David Y</pubmed_authors><pubmed_authors>Sidoli S</pubmed_authors><pubmed_authors>Vinson DA</pubmed_authors><pubmed_authors>Zhao S</pubmed_authors><pubmed_authors>Dierdorff L</pubmed_authors><pubmed_authors>Vostal L</pubmed_authors><pubmed_authors>Upad A</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Fulton SL</pubmed_authors><pubmed_authors>Kong L</pubmed_authors><pubmed_authors>Dutta S</pubmed_authors><pubmed_authors>Chan JC</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Zheng Q</pubmed_authors><pubmed_authors>Ramakrishnan A</pubmed_authors><pubmed_authors>Di Salvo G</pubmed_authors><pubmed_authors>Muir TW</pubmed_authors><pubmed_authors>Bastle RM</pubmed_authors><pubmed_authors>Maze I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bidirectional histone monoaminylation dynamics regulate neural rhythmicity.</name><description>Histone H3 monoaminylations at Gln5 represent an important family of epigenetic marks in brain that have critical roles in permissive gene expression&lt;sup>1-3&lt;/sup>. We previously demonstrated that serotonylation&lt;sup>4-10&lt;/sup> and dopaminylation&lt;sup>9,11-13&lt;/sup> of Gln5 of histone H3 (H3Q5ser and H3Q5dop, respectively) are catalysed by transglutaminase 2 (TG2), and alter both local and global chromatin states. Here we found that TG2 additionally functions as an eraser and exchanger of H3 monoaminylations, including H3Q5 histaminylation (H3Q5his), which displays diurnally rhythmic expression in brain and contributes to circadian gene expression and behaviour. We found that H3Q5his, in contrast to H3Q5ser, inhibits the binding of WDR5, a core member of histone H3 Lys4 (H3K4) methyltransfera</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-02T13:15:04.458Z</modification><creation>2025-04-19T18:19:32.693Z</creation></dates><accession>S-EPMC11754111</accession><cross_references><pubmed>39779849</pubmed><doi>10.1038/s41586-024-08371-3</doi></cross_references></HashMap>